Trial

Indicated for treatments that reduce hard or compact adiposities.

PREVENTS: Decreases Lipogenesis, which is fundamentally carried out by an inhibition of the glucose transporter inside the adipocyte (Glut4) and an inhibition of the synthesis of intra-adipocyte fatty acids

ELIMINATES: Stimulates Lipolysis through a direct stimulation of Hormone Sensitive Lipase and an inhibition of Phosphodiesterase with the consequent intra-adipocyte increase of AMPc.

MAINTAINS: Decreases Adipogenesis, this is carried out fundamentally by an inhibition of the activity of perilipin, which allows a greater activity of the Sensitive Hormone Lipase at the level of the fat vacuole. Avoid the rebound effect.